127 related articles for article (PubMed ID: 8944330)
1. Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients.
Maehle BO; Tretli S
Breast Cancer Res Treat; 1996; 41(2):123-30. PubMed ID: 8944330
[TBL] [Abstract][Full Text] [Related]
2. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status.
Maehle BO; Tretli S; Skjaerven R; Thorsen T
Breast Cancer Res Treat; 2001 Jul; 68(2):159-69. PubMed ID: 11688519
[TBL] [Abstract][Full Text] [Related]
3. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status.
Maehle BO; Tretli S; Thorsen T
APMIS; 2004 Jun; 112(6):349-57. PubMed ID: 15511272
[TBL] [Abstract][Full Text] [Related]
4. Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand.
McNee RK; Mason BH; Neave LM; Kay RG
Breast Cancer Res Treat; 1987; 9(2):145-50. PubMed ID: 3620716
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years.
Törnberg SA; Carstensen JM
Br J Cancer; 1994 Feb; 69(2):358-61. PubMed ID: 8297735
[TBL] [Abstract][Full Text] [Related]
6. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors.
Verreault R; Brisson J; Deschênes L; Naud F
Am J Epidemiol; 1989 Feb; 129(2):260-8. PubMed ID: 2912039
[TBL] [Abstract][Full Text] [Related]
7. Season of tumour detection influences factors predicting survival of patients with breast cancer.
Mason BH; Holdaway IM; Stewart AW; Neave LM; Kay RG
Breast Cancer Res Treat; 1990 Jan; 15(1):27-37. PubMed ID: 2328328
[TBL] [Abstract][Full Text] [Related]
8. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
9. Relationship of body mass index with prognosis in breast cancer patients treated with adjuvant radiotherapy and chemotherapy.
Cihan YB
Asian Pac J Cancer Prev; 2014; 15(10):4233-8. PubMed ID: 24935376
[TBL] [Abstract][Full Text] [Related]
10. Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: a retrospective review.
Kaviani A; Neishaboury M; Mohammadzadeh N; Ansari-Damavandi M; Jamei K
Asian Pac J Cancer Prev; 2013; 14(4):2225-9. PubMed ID: 23725117
[TBL] [Abstract][Full Text] [Related]
11. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study.
Vatten LJ; Foss OP; Kvinnsland S
Eur J Cancer; 1991; 27(5):641-6. PubMed ID: 1828977
[TBL] [Abstract][Full Text] [Related]
12. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
13. Association between prognosis and hormone receptors in women with breast cancer.
Papatestas AE; Miller SR; Pertsemlidis D; Fagerstrom R; Lesnick G; Aufses AH
Cancer Detect Prev; 1986; 9(3-4):303-10. PubMed ID: 3742506
[TBL] [Abstract][Full Text] [Related]
14. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
15. Survival of women with node negative breast cancer in the Auckland region.
Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
[TBL] [Abstract][Full Text] [Related]
16. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
[TBL] [Abstract][Full Text] [Related]
17. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
18. Defining a high mortality risk group among women with primary breast cancer.
Nordén T; Lindgren A; Bergström R; Holmberg L
Br J Cancer; 1994 Mar; 69(3):520-4. PubMed ID: 8123483
[TBL] [Abstract][Full Text] [Related]
19. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
Kaufmann M; Klinga K; Kühn W; Abel U
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
[TBL] [Abstract][Full Text] [Related]
20. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
